Vaxin Inc.

Vaxin Inc. is a vaccine development company founded in 1997 by De-chu Tang to commercialize his research at UAB. It is currently working on vaccines for influenza and anthrax, largely with funding from the U.S. Department of Health and Human Services. Research is also being conducted toward vaccine programs for avian influenza, tetanus and Alzheimer's.

Vaxin moved its laboratories into Birmingham's Innovation Depot in 2007. Bill Enright became CEO in 2008. He and other executives worked from offices in Gaithersburg, Maryland. In Spring 2012 the company, with 8 full-time employees, consolidated its operations in Maryland.

Vaxin, partly owned by the UAB Research Foundation, is partnering with fellow Innovation Depot tenant Soluble Therapeutics in seeking grants related to studying vaccine stabliity.

References

• Swant, Martin (July 27, 2012) "Vaxin moves from Birmingham to Maryland." The Birmingham News

External links

• Vaxin Inc. website